Bacteria as tumour-targeting vectors (Q35215803)

7 August 2017

1 reference

title

Bacteria as tumour-targeting vectors (English)

1 reference

7 August 2017

David Bermudes

3

1 reference

ORCID Public Data File 2021

author name string

John M Pawelek

series ordinal

1

1 reference

7 August 2017

K Brooks Low

series ordinal

2

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Lancet Oncology Commission

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

548-556

1 reference

II. Contribution to the Knowledge of Sarcoma

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Potent antitumor activity of a urokinase-activated engineered anthrax toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Effect of Histolyticus Infection and Toxin on Transplantable Mouse Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Chemotherapeutic tumour targeting using clostridial spores

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Clostridium spores for tumor-specific drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Combination bacteriolytic therapy for the treatment of experimental tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Antitumor activity of Bifidobacterium spp. isolated from a healthy Korean

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Infection of a secondary carcinoma by Salmonella montevideo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Abscess formation in a pheochromocytoma; report of a case due to Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

A malignant pleural effusion infected with Salmonella enteritidis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Commentary: pleural empyema and malignancy--another dimension

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Tumour-selective Salmonella-based cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Salmonella pathogenicity island 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Identification of a pathogenicity island required for Salmonella survival in host cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Mutations in Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and resistance to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

A Salmonella virulence protein that inhibits cellular trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Salmonella pathogenicity island-2 and anticancer activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Anticytokine strategies in the treatment of the systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

A lethal role for lipid A in Salmonella infections

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Extragenic suppressors of growth defects in msbB Salmonella.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Expression of herpes simplex virus type I thymidine kinase gene in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

Antitumour effects of genetically engineered Salmonella in combination with radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901194-X

7 January 2021

10.1016/S1470-2045(03)01194-X

Identifiers

DOI

1 reference

7 August 2017

1 reference